Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Neurocrine Biosciences (NBIX) over the last 15 years, with Q4 2025 value amounting to $59.5 million.

  • Neurocrine Biosciences' Other Non-Current Assets rose 1442.31% to $59.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $59.5 million, marking a year-over-year increase of 1442.31%. This contributed to the annual value of $59.5 million for FY2025, which is 1442.31% up from last year.
  • Neurocrine Biosciences' Other Non-Current Assets amounted to $59.5 million in Q4 2025, which was up 1442.31% from $20.3 million recorded in Q3 2025.
  • Neurocrine Biosciences' Other Non-Current Assets' 5-year high stood at $355.8 million during Q1 2021, with a 5-year trough of $3.2 million in Q2 2021.
  • For the 4-year period, Neurocrine Biosciences' Other Non-Current Assets averaged around $57.0 million, with its median value being $43.1 million (2023).
  • As far as peak fluctuations go, Neurocrine Biosciences' Other Non-Current Assets crashed by 9925.32% in 2021, and later soared by 10441.77% in 2024.
  • Over the past 4 years, Neurocrine Biosciences' Other Non-Current Assets (Quarter) stood at $3.2 million in 2021, then surged by 1450.0% to $49.6 million in 2023, then grew by 4.84% to $52.0 million in 2024, then grew by 14.42% to $59.5 million in 2025.
  • Its Other Non-Current Assets stands at $59.5 million for Q4 2025, versus $20.3 million for Q3 2025 and $21.6 million for Q2 2025.